2-Cyclohexylmandelic acid | CAS:4335-77-7

We serve 2-Cyclohexylmandelic acid CAS:4335-77-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 2-Cyclohexylmandelic acid

Chemical Name: 2-Cyclohexylmandelic acid
CAS.NO:  4335-77-7
Synonyms:
α-Cyclohexylmandelic acid
alpha-Cyclohexylmandelic acid
α-Cyclohexyl-DL-mandelic Acid
2-cyclohexyl-2-hydroxy-2-phenylacetic acid

Molecular Formula:  C14H18O3
Molecular Weight: 234.29100

Physical and Chemical Properties:
Density: 1.206 g/cm3
Boiling point: 408.6ºC at 760 mmHg
Melting point: 163 °C
Flash point: 215.1ºC
Refractive index:1.574

Specification:
Appearance: white crystalline powder
Purity:≥98%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:-20ºC Freezer.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Oxybutynin hydrochloride  CAS:1508-65-2
Intermediates of Oxybutynin  CAS:5633-20-5



Contact us for information like 2-Cyclohexylmandelic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-cyclohexyl-2-hydroxy-2-phenylacetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,α-Cyclohexyl-DL-mandelic Acid Use and application,2-cyclohexyl-2-hydroxy-2-phenylacetic acid technical grade,usp/ep/jp grade.


Related News: China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.D-Alanine manufacturer Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.2-Naphthaleneboronic acid supplier The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.Ethyl 2-Bromoisovalerate vendor The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.